The Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, said GlaxoSmithKline (GSK) Consumer Nigeria’s impending exit is not to blame for...
Hello, and welcome to Business Roundup this week. Here, we bring you highlights of events that happened during the week -from the capital market to the...
Leading drug-maker, GlaxoSmithKline Consumer Nigeria Plc recorded a 12.8% uptrend in its gross earnings for full year 2019, its annual report and financial statements, published by the...
The market was bullish throughout last week, adding up N694.335 billion or 5.59% week on week as the appetite for investment deepened across the investing public....
Pharmaceutical and healthcare company, GlaxoSmithKline Consumer Nigeria Plc has reported a 2% drop in its after-tax for the year ended, 31 December 2019 despite improvement in...
GlaxoSmithKline Consumer Nigeria (GSK Nigeria) Plc has effectively secured the mandate to sell its drink business as shareholders of the company approved the divestment to Suntory...
The board of directors of GlaxoSmithKline Consumer Nigeria (GSK Nigeria) Plc is proposing to pay a special dividend of N716 million to shareholders under the proposed...
The board of directors of GlaxoSmithKline Consumer Nigeria (GSK) Plc has accepted a binding offer from a Japanese firm, Suntory Beverage & Food Nigeria Limited, a...
